These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 9143407)

  • 1. Growth kinetic study of human hepatocellular carcinoma using proliferating cell nuclear antigen and Lewis Y antigen: their correlation with transforming growth factor-alpha and beta 1.
    Yamaguchi M; Yu L; Hishikawa Y; Yamanoi A; Kubota H; Nagasue N
    Oncology; 1997; 54(3):245-51. PubMed ID: 9143407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lewis Y antigen expression in hepatocellular carcinoma. An immunohistochemical study.
    Wakabayashi M; Shiro T; Seki T; Nakagawa T; Itoh T; Imamura M; Shiozaki Y; Inoue K; Okamura A
    Cancer; 1995 Jun; 75(12):2827-35. PubMed ID: 7539714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathologic features and prognosis of resected hepatocellular carcinomas of varied sizes with special reference to proliferating cell nuclear antigen.
    Suehiro T; Matsumata T; Itasaka H; Yamamoto K; Kawahara N; Sugimachi K
    Cancer; 1995 Aug; 76(3):399-405. PubMed ID: 8625120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue hepatocyte growth factor and proliferating cell nuclear antigen in hepatocellular carcinoma.
    Huang GT; Lee HS; Chen CH; Chiou LL; Lee CZ; Chen DS; Hsu HC; Sheu JC
    J Formos Med Assoc; 1999 Feb; 98(2):92-6. PubMed ID: 10083763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transforming growth factor-alpha and epidermal growth factor receptor in chronic liver disease and hepatocellular carcinoma.
    Harada K; Shiota G; Kawasaki H
    Liver; 1999 Aug; 19(4):318-25. PubMed ID: 10459631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transforming growth factor-alpha, epidermal growth factor receptor, and PCNA immunoexpression in uterine leiomyosarcomas and leiomyomas in B6C3F1 mice.
    Moore AB; He H; Yoshida A; Rico PJ; Haseman JK; Dixon D
    Exp Toxicol Pathol; 2000 Jun; 52(3):195-200. PubMed ID: 10930119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transforming growth factor-alpha in human hepatocellular carcinoma and coexpression with hepatitis B surface antigen in adjacent liver.
    Hsia CC; Axiotis CA; Di Bisceglie AM; Tabor E
    Cancer; 1992 Sep; 70(5):1049-56. PubMed ID: 1325266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Greater expression of transforming growth factor alpha and proliferating cell nuclear antigen staining in mouse hepatoblastomas than hepatocellular carcinomas induced by a diethylnitrosamine-sodium phenobarbital regimen.
    Sakairi T; Kobayashi K; Goto K; Okada M; Kusakabe M; Tsuchiya T; Sugimoto J; Sano F; Mutai M
    Toxicol Pathol; 2001; 29(4):479-82. PubMed ID: 11560253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of combination study of apoptotic factors and proliferating cell nuclear antigen in estimating the prognosis of hepatocellular carcinoma.
    Osada S; Saji S; Kuno T
    J Surg Oncol; 2004 Jan; 85(1):48-54. PubMed ID: 14696087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical stains of proliferating cell nuclear antigen, insulin-like growth factor 2 and clusterin help distinguish malignant from benign liver nodular lesions.
    Lai JP; Chen ZM; Lok T; Chan OT; Himmelfarb E; Zhai Q; Lin F; Wang HL
    J Clin Pathol; 2014 Jun; 67(6):464-9. PubMed ID: 24407433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of hepatocyte growth factor, transforming growth factor alpha, and transforming growth factor beta 1 messenger RNA in various human liver diseases and correlation with hepatocyte proliferation.
    Masuhara M; Yasunaga M; Tanigawa K; Tamura F; Yamashita S; Sakaida I; Okita K
    Hepatology; 1996 Aug; 24(2):323-9. PubMed ID: 8690400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationships among the expression of epidermal growth factor receptor, proliferating cell nuclear antigen labeling index, and lymph node metastasis in gastric cancer.
    Iida A; Hirose K; Arai M; Yamaguchi A; Nakagawara G
    Oncology; 1995; 52(3):189-95. PubMed ID: 7715902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The assessment of proliferating cell nuclear antigen immunohistochemical staining in small hepatocellular carcinoma and its relationship to histologic characteristics and prognosis.
    Kitamoto M; Nakanishi T; Kira S; Kawaguchi M; Nakashio R; Suemori S; Kajiyama G; Asahara T; Dohi K
    Cancer; 1993 Sep; 72(6):1859-65. PubMed ID: 8103417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular apoptosis susceptibility protein and proliferation in human hepatocellular carcinoma.
    Shiraki K; Fujikawa K; Sugimoto K; Ito T; Yamanaka T; Suzuki M; Yoneda K; Sugimoto K; Takase K; Nakano T
    Int J Mol Med; 2006 Jul; 18(1):77-81. PubMed ID: 16786158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of transforming growth factor-alpha in hepatocellular carcinoma and focal nodular hyperplasia from European patients.
    Schaff Z; Hsia CC; Sarosi I; Tabor E
    Hum Pathol; 1994 Jul; 25(7):644-51. PubMed ID: 8026823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P21/WAF1 is an independent survival prognostic factor for patients with hepatocellular carcinoma after resection.
    Kao JT; Chuah SK; Huang CC; Chen CL; Wang CC; Hung CH; Chen CH; Wang JH; Lu SN; Lee CM; Changchien CS; Hu TH
    Liver Int; 2007 Aug; 27(6):772-81. PubMed ID: 17617120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of the G1-S modulators in hepatitis B virus-related hepatocellular carcinoma and dysplastic nodule: association of cyclin D1 and p53 proteins with the progression of hepatocellular carcinoma.
    Choi YL; Park SH; Jang JJ; Park CK
    J Korean Med Sci; 2001 Aug; 16(4):424-32. PubMed ID: 11511787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nodules of less-differentiated tumor within or adjacent to hepatocellular carcinoma: relative expression of transforming growth factor-alpha and its receptor in the different areas of tumor.
    Morimitsu Y; Hsia CC; Kojiro M; Tabor E
    Hum Pathol; 1995 Oct; 26(10):1126-32. PubMed ID: 7557946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical expression of p53 protein and proliferating cell nuclear antigen in hepatocellular carcinoma.
    Nakopoulou L; Janinis J; Giannopoulou I; Lazaris AC; Koureas A; Zacharoulis D
    Pathol Res Pract; 1995 Dec; 191(12):1208-13. PubMed ID: 8927568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [DNA ploidy pattern, p53 immunohistochemical overexpression and PCNA labeling index in "single nodular" human hepatocellular carcinomas from the viewpoint of biological malignant potential].
    Saiki I; Une Y; Uchino J
    Gan To Kagaku Ryoho; 1995 Jun; 22 Suppl 2():103-9. PubMed ID: 7611770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.